Latest filing published 07 Mar 2024 for Y-mAbs Therapeutics, Inc., €26k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Susan Laura Smith: trading record in brief
All filings by Susan Laura Smith on record concern Y-mAbs Therapeutics, Inc. The record holds 3 filings, for trades running from 17 January 2023 to 5 March 2024.
The open-market record consists of 1 sale worth €26k, with no purchase. The rest of the record consists of 2 share grants. Since January 2024: no purchases and 1 sale on the market.
The newest entry dates from 7 March 2024: an open-market sale of €26k, in Y-mAbs Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Susan Laura Smith
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,682 shares@ US$16.55100.0% of flowCommon StockSEC:0001104659-24-031939:0
- 17,800 shares0Common StockSEC:0001415889-24-001649:0
- 17,800 shares0Common StockSEC:0001104659-23-005033:0
3 of 3 declarations